PE firm to buy Cambrex for $2.4B amid flurry of CDMO acquisitions
Cambrex has agreed to a $2.4B acquisition by an affiliate of the Permira funds. Shareholders will receive $60 per share, a 47.1% premium to Tuesday’s closing price.
Under the agreement, Cambrex has 45 days to solicit a better deal. The company won’t disclose any developments during this period unless the board decides on a different agreement.
